factual

Harm Evidence Is Mostly First-Person Anecdotes

FDA approval mainly requires two positive RCTs showing benefit over placebo or competitor, with thin safety data at that stage; the vast majority of harm evidence comes only after approval, and that post-approval evidence amounts to a collection of first-person anecdotes uploaded to databases, with carefully controlled randomized harm trials being rare.

factualpending

Speaker

Jacob Stegenga

Evidence Quote

“The vast, vast majority of evidence that we get on the harmful side of exit[?] drugs occurs after the drug has been approved for public consumption. And at that point, there's no incentive to do any more careful randomized trials.”

Source

Jacob Stegenga on Medical Nihilism— EconTalk
Created: 6/13/2026, 12:09:58 AM

Your notes

Loading notes...